Perioperative Morbidity of Open Versus Minimally Invasive Partial Nephrectomy: A Contemporary Analysis of the National Surgical Quality Improvement Program
Overview
Urology
Authors
Affiliations
Introduction And Objectives: In recent years, there has been a shift to minimally invasive partial nephrectomy (MIPN) with the dissemination of robot-assisted technology. However, contemporary data on the comparative morbidity of open partial nephrectomy (OPN) and MIPN are lacking. We, therefore, evaluated the perioperative morbidity of OPN and MIPN using a contemporary national cohort.
Methods: We identified 13,658 patients aged 18 to 89 who underwent PN from 2010 to 2015 in the National Surgical Quality Improvement Program (NSQIP) database, of whom 9018 (66.0%) underwent MIPN. The associations of MIPN with 30-day morbidity were evaluated using logistic regression, adjusted for patient features.
Results: Median age at surgery was 60 (interquartile range [IQR] 51, 68) years. Overall, 30-day complications occurred in 6.7% of patients. Compared with OPN, MIPN was associated with lower rates of 30-day complications (4.9% vs 10.1%, p < 0.0001), perioperative blood transfusion (3.8% vs 12.5%, p < 0.0001), prolonged hospitalization (5.6% vs 23.4%, p < 0.0001), readmission (4.4% vs 7.8%, p < 0.0001), reoperation (1.8% vs 3.2%, p < 0.0001), and 30-day mortality (0.3% vs 0.6%, p = 0.001). On multivariable analysis, MIPN was independently associated with a reduced risk of 30-day complications (odds ratio [OR] 0.46, p < 0.0001), perioperative blood transfusion (OR 0.27, p < 0.0001), prolonged hospitalization (OR 0.19, p < 0.0001), readmission (OR 0.59, p < 0.0001), and reoperation (OR 0.57, p < 0.0001). Postoperative complications occurred predominantly early after surgery, whereas hospital readmissions and reoperation occurred at a consistent rate.
Conclusions: In this contemporary national cohort, MIPN was independently associated with reduced rates of 30-day complications, perioperative blood transfusion, prolonged hospitalization, hospital readmission, and reoperation, compared with OPN.
Ayoub E, Kutchukian S, Bigot P, Dinh A, Gondran-Tellier B, Robin H World J Urol. 2024; 42(1):179.
PMID: 38507063 DOI: 10.1007/s00345-024-04853-1.
Bic A, Mazeaud C, Salleron J, Bannay A, Balkau B, Larose C BMC Urol. 2023; 23(1):146.
PMID: 37715175 PMC: 10502976. DOI: 10.1186/s12894-023-01322-6.
Shah Y, Simhal R, Wang K, Goldberg H, Lallas C, Chandrasekar T J Clin Med. 2023; 12(1).
PMID: 36614976 PMC: 9821707. DOI: 10.3390/jcm12010175.
El-Asmar J, Ayoub C, Kfoury P, Abou-Mrad A, El-Hajj A World J Surg. 2022; 47(4):856-862.
PMID: 36587175 DOI: 10.1007/s00268-022-06869-3.
Adem R, Hassen S, Abdulaziz M, Ahmed A, Jemberie A, Gebeyehu Y Res Rep Urol. 2022; 14:389-397.
PMID: 36394071 PMC: 9661989. DOI: 10.2147/RRU.S376720.